DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Cipla Share Price Live Updates: Cipla News

Economic Times 7 hrs ago·12 Aug 2026, 2:56 am

Cipla's stock is currently in focus as the company updates investors on its latest developments and business performance. The focus is on understanding the factors driving the stock's movement and the broader implications for the company's future.

For investors, this news is significant as it provides insight into Cipla's operational health and strategic direction. Any updates regarding product pipelines, regulatory approvals, or market performance can directly influence the company's valuation and investor sentiment.

Moving forward, investors should monitor the company's official announcements for specific details. Keeping an eye on market reactions and subsequent earnings reports will be crucial to gauge the long-term impact of these updates on the stock.